Indian Pharma Stocks Surge on US Price Order

  Published 1 year ago

Indian pharmaceutical stocks rallied after the US HHS announced it expects branded drugmakers to align US prices with peer nations. Analysts believe this benefits generic and biosimilar companies, reversing a previous dip caused by Trump's price-cut order.

  • NIPHARM index climbed 1.7%, leading sectors.
  • Gland Pharma jumped 4%, leading stock gains.
  • Generic/biosimilar firms see 'big relief'.

You might like these

Google Invests $5M in Alberta AI Skills

GMR Airports Traffic Rises in Q1

Brigade Q2 Profit Surges 17% YoY

Nitco Challenges Infomerics Rating

Borosil Shifts Focus to India's Solar Growth

Sarveshwar Foods Lands Singapore Deal

Sobha Ltd. Stock Surges on Positive Brokerage Reports

News that matters the most ⚡